|
|
GeneNews Limited - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for GeneNews Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
GeneNews Limited. The Group's principal activity is to develop proprietary molecular diagnostic tests for diseases with unmet clinical needs and large commercial opportunities. The tests are based on the Company's breakthrough Sentinel Principle and are being developed in the areas of cancer, cardiovascular diseases, central nervous system disorders and arthritis. The Group operates only in the Canada.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|